首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-mouse CD4 Antibody
产品名称:
PerCP/Cyanine5.5 anti-mouse CD4 Antibody
产品类别:
抗体
产品编号:
100433
产品应用:
100433
[价格]
规格 价格 库存
25µg ¥ 1416 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis.?For flow cytometric staining, the suggested use of this reagent is = 0.25 ?g per 106 cells in 100 ?l. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation.?Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin < 0.01 EU/?g).

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  13. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
  2. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  3. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  4. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  5. Acker A, et al. 2014. PLoS One. 9:110015. PubMed
  6. Miao L, et al. 2020. Theranostics. 0.7625. PubMed
  7. Li X, et al. 2019. Mol Med Rep. 19:4195. PubMed
  8. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  9. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  10. Gawish R, et al. 2022. Elife. 11:. PubMed
  11. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  12. Gr?deland G, et al. 2020. Front Immunol. 11:431. PubMed
  13. Wei H, et al. 2021. Malar J. 20:89. PubMed
  14. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  15. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  16. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  17. White MPJ, et al. 2020. Front Immunol. 11:1830. PubMed
  18. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  19. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  20. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  21. Nagai Y, et al. 2019. Front Immunol. 10:174. PubMed
  22. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  23. Hoffmann A, et al. 2021. EBioMedicine. 71:103568. PubMed
  24. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  25. Flaherty S, Reynolds J 2015. J Vis Exp. 98: 52739. PubMed
  26. Wu HL, et al. 2018. J Immunol. 200:49. PubMed
  27. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  28. LaMothe RA et al. 2018. Front Immunol. 0.570138889 . PubMed
  29. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  30. Anderson AM, et al. 2018. J Immunol. 200:2057. PubMed
  31. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  32. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  33. Rivadeneira DB, et al. 2020. Immunity. 51(3):548-560. PubMed
  34. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  35. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  36. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  37. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  38. Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
  39. Wang H, et al. 2021. Malar J. 20:249. PubMed
  40. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  41. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  42. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  43. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  44. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  45. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  46. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  47. Chen Z, et al. 2014. Cancer Immunol Res. 2:911. PubMed
  48. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  49. Xing Y, et al. 2022. Cancer Lett. 529:100. PubMed
  50. Vogel A, et al. 2022. STAR Protoc. 3:101653. PubMed
  51. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  52. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  53. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  54. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  55. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  56. Kim MY, et al. 2017. Plant Biotechnol J. 1.729166667. PubMed
  57. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  58. Song P, et al. 2018. Int J Mol Med. 41:935. PubMed
  59. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  60. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  61. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  62. Pandey S, et al. 2014. J Immunol. 193:3632. PubMed
  63. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  64. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  65. Wang Y, et al. 2022. J Control Release. 349:118. PubMed
  66. Abhyankar MM, et al. 2018. NPJ Vaccines. 3:22. PubMed
  67. Ahn SH, et al. 2022. Front Endocrinol (Lausanne). 13:846226. PubMed
  68. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  69. Li H, et al. 2021. Protein Cell. Online ahead of print. PubMed
  70. Iwata TN, et al. 2018. Mol Cancer Ther. 17:1494. PubMed
  71. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  72. Tsai SJ, et al. 2021. J Biol Chem. 297:101266. PubMed
  73. Li H, et al. 2021. Front Immunol. 12:739605. PubMed
  74. Chen HL, et al. 2021. Pharm Biol. 59:134. PubMed
  75. Suhail A, et al. 2019. Cell Rep. 29:3522. PubMed
  76. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  77. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  78. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  79. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  80. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  81. Vijay R, et al. 2021. J Exp Med. 218:. PubMed
  82. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  83. Jeon Y, et al. 2015. PLoS One. 10: e0139845. PubMed
  84. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  85. Bommareddy PK, et al. 2019. J Biol Methods. 6:2. PubMed
  86. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  87. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  88. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
  89. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  90. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  91. Vijay R, et al. 2020. Nat Immunol. 21:790. PubMed
  92. Li Y, et al. 2020. Front Cell Dev Biol. 8:604021. PubMed
  93. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  94. Konishi Y, et al. 2018. iScience. 10:98. PubMed
  95. Zheng Y, et al. 2022. Transl Res. :. PubMed
  96. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  97. Gawish R, et al. 2022. Elife. 11:. PubMed
  98. Zeng F, et al. 2021. J Invest Dermatol. 596:141. PubMed
  99. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  100. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  101. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  102. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
RRID
AB_893330 (BioLegend Cat. No. 100433) AB_893324 (BioLegend Cat. No. 100434)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线